Trafalgar International GCAN
OTC GCAN
$0.25 -0.08 (-24.24%)
At close: Aug 18, 2026 · 4:00 PM UTC

Trafalgar International (GCAN) Revenue Growth (1y) (2018 - 2021)

Trafalgar International (GCAN) Revenue Growth (1y) (2018 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Haleon 43.96 Bn 43.00 Bn - -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn -0.81%
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn -0.24%
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn 0.07%
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn -1.92%
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn 4.88%
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn 39.49%
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn 10.23%
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Trafalgar International 236,233.75 236,233.75 - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -73.71%
Dec 31, 2019 -94.82%
Jun 30, 2018 30,671.23%